LINC00494 and ovarian carcinoma: To conclude, the above-mentioned findings elaborated the anti-cancer action of downregulation of LINC00494 in ovarian cancer by curbing migration and invasion of cancer cells, while NFκB1-mediated overexpression of FBXO32 had the capability to override the favorable effects induced by LINC00494 knockdown.